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Of&dvs. We examined the atility af the 32.point QRS score 
fnmt the Wead eketroeerdiograa (Ecc) for anxswemeat of 
tkiSCbdCrisk~dinfaretSizeiBpti~tSrereiviag 
thIwllhoiytictberapy. 
~TheQRSscareoltersameaasofevahmtiagtlte 
tkmpeatlc beneat of tllromholytk therapy by comparing aMl 
intardsizewiththelaitialexteatofisdiemic~ 
M~.TbpstudyIocitlded38pa~ls(34olea,4wamen; 
mean [*SD] age 54 i IO years) with a first idrction (18 
anterior, 20 infdiorh ‘he maximal potential QRS score (Qw 
mlsassignedtoallkadswitb~ltnJ-~Vsr-ontlleieitial 
ECC.TheQRSscareswerecakulatedat7aad3Odaysaftcr . . 
Rewtis. llte QRS, was 103 f 3.1 (mean z!z SD) for aateriar 
and1@.4~35forinkbri11fm%~QRSsro~s~simihu 
at7aad38dnysforbathMlerlor(5~~3Avs55*33A)rpd 
inFeriorislprcts(3.7*16vs.29*22).~day7QRsMore~ 
ejectionthclhat1monthmereinvcdy~tol(r=-9.7% 
p<ael).Tben-281perfb~defed~34*ll%oltbe~ 
ventridefarantahrand32~7%foripferior~~ 
quest Tc-!Bm pyropbospaPteidUCtSiWWiU15~!%Oftkkft 
ventrideforuterioraBd17*9%for~~mQRSg 
was-withtheextentofrheTl-2gl~detoct(r= 
8.79,p<~1),and~day7QRsscore~correlatedaitb 
Tc4!ho pympbpbte inlard size (r = tL79, p < 0.W). 
llhrctmLeftven~$ect~fra~was-hy 
radiolIe venbieolagraphy at 1 moath. nventy4glat patie!mts 
had thaRiMl (II)-201 and tedl~um (lk)mBl pympbphate 
mpbic mea mefmntoftheischemicregionandinfarctsix 
ckwdush..32-pointQRssaKecanpmvidrdimme- 
diate nnmslveewds oftbeicickmicriskrrgioa~~t 
hlfartt sin?. 
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A major determinant of prognosis after myocardial infarction 
is left ventricular systolic function, which is inversely related to 
the extent of infarction (1,2). Clinical trials show that throm- 
bolytic therapy results in better left ventricular function and 
improved survival after infarction in large patient groups (3,4), 
but the benefits of thrombolysii in individual patients may be 
mo-: ditlicult to ascertain. Important questions are how much 
myocardium is ischemic during the acute stage of infarction, 
that is, the size of the ischemic risk region, and subsequently, 
how much myocardial salvage has been achieved in the indi- 
vidual. These questions are relevant to determining optimal 
initial treatment, management during the convalescent period 
and evaluation of treatment benefit. 
At present, the principal means of measuring the ischemic 
risk region and infarct size is single-photon emission computed 
tomography, which allows ret-e annparison of the 
extent of the risk region and infarct size (5,6). A limitation of 
this approach is that important information about the extent of 
ischemic myocardium may not be available when it is most 
needed, such as during the zscssment and treatment of the 
patient in the emergency room. A widely applicable method 
that allows immediate estimation of the extent of ischemic 
myocardium and comparison with later infarct size would be 
useful for early risk stratilication of patients with acute myo- 
cardial infarction. Some electrocardiographic (ECG) methods 
were developed to estimate infarct size in the prethromboiytic 
em (7,8), but rite application of these tech@Ks in patients 
receiving rhrombolytic rherapy has not been proven. 
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The Selvester QRS score, calculated from the sta&ud 
lZleadECG,hasbeenproposedasameasureofinfardsize 
(9,lO). This QRS scoring t+&m was originally derived from 
computer simulations of the ECG and a 2!+oint version of the 
system was validated with anatomic data for both anterior and 
inferior i&ucts (l&12). In both groups, the sumrued QRS 
swrewascQlTelatedwiththeanatomiciafarc&si7.e,andeaeh 
pointoftheQRSscorecorrespoaded toinfar&Qof-396of 
the left ventricular ma.% (11,12). subsequentty, the sealing 
systemwasrevisedtoa32-@ntsysteminordertobeUer 
de&be inferior and posterolateral infare& (13,14). This QRS 
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score has since been applied in clinical studies (15-17) but were recorded in left anterior oblique. anterior, left posterior 
questions have remained concerning the utility of the score in oblique and left lateral projections for 10 min each with 16 
patients receiving thrombolytic therapy (18). This study there- ECG gating intervals. The ventriculograms were analyzed by 
fore addressed the application of the 32point QRS score to technologists who were blinded to the clinical data, using a 
measurement of the extent of the ischemic risk region and of semiautomatic edge-detection algorithm (22). The ejection 
subsequent infarct size in patients treated with thrombolytic fraction is reported as a percentage of the left ventricular 
therapy. end-diastolic volume. 
Methods 
Patient group. This study was performed prospectively in 
38 patients presenting to hospital with a first myocardial 
infarction. Transmural myocardial ischemia was diagnosed in 
the presence of typical central chest pain of greater than 
30 min duration and ST segment elevation 2100 ~LV (at 60 ms 
after the J point) in two or more contiguous leads on the 
1Zlead ECG. Exclusion criteria were age >75 years, concom- 
itant valvular or myopathic heart disease, previous myocardial 
infarction or coronary artery bypass surgery. Patients with 
ECG evidence of left ventricular hypertrophy or right or left 
bundle branch block were also excluded. All patients gave their 
written, informed consent to participate in the study, which 
had been previously approved by the Ethics Committee of the 
hospital. Patients were treated with aspirin, topical nitrates and 
thrombolytic therapy (streptokinase, 1.5 million U intrave- 
nously over 60 min, or tissue plasminogen activator, 100 mg 
intravenously over 3 h) and intravenous heparin, according to 
usual clinical practice. Other treatment and subsequent inves- 
tigation with coronary angiography was at the discretion of the 
attending physician. 
Electracardiogram QRS scoring. The admission 1Zlead 
ECG with the greatest total sum of ST elevation was identified, 
and the site of infarction determined. For anterior infarcts, the 
relevant leads were I, aVL and V, to Vb; for inferior and 
inferoposterior infarcts, the leads were II, aVF and V, to V,, 
and also leads V, and V, for posterior infarction (19,20). The 
relevant leads showing ~lOO-~V ST segment elevation (or 
~100-/~V ST depression in leads V, to V, for inferoposterior 
infarcts) were assigned the corresponding maximal possible 
QRS score for that lead according to the 32-point scoring 
system <!3,14). These initial QRS scores were summed (po- 
tcntial QRS score, QRS,,) to give an index of potential 
maximal infarct size. Serial 12-lead ECGs were recorded on 
days 1, 3, 7 and 30 after infarction, using the same lead 
positions as those of the initial recording. All ECGs were 
manually scored by two independent observers, and any dif- 
ferences were resolved by consensus with a third observer. 
Radtonuclide ventricotography. All patients underwent 
resting equilibrium radionuclide ventriculography for mea- 
surement of left ventricular ejection fraction at 2 days and l 
month after infarction. The patient’s erythrocytes were labeled 
in vivo by intravenous injection of 10 @kg of stannous 
pyrophosphate, followed by 15 to 25 mCi of technetium 
(Tc)-99m as per&mate intravenously (21). The studies were 
performed on a small-field-of-view (3O-cm diameter) mobile 
gamma camera (GE) with a 30” slant-hole collimator. Images 
Single-photon emission computed tomogmpby. Ten pa- 
tients were unable to have tomographic studies because the 
nuclear medicine laboratory was not available on weekends, 
when their studies were due. In the other 28 patients the 
potential maximal QRS score and the day 7 QRS score were 
compared with thallium (II)-201 measurements of the regional 
myocardial perfusion defect and Tc-99m pyrophosphate mea- 
surements of infarct size. In 10 patients, the TI-201 study was 
performed at the time of presentation, and the Tl-201 was 
administered before infusion of the thrombolytic agent, with 
tomographic imaging performed immediately thereafter. Ra- 
dionuclide surface markers were employed, and patient and 
camera position recorded, to ensure correct registration of the 
Tc-99m pyrophosphate study on day 5. In the other 18 patients, 
simultaneous Tl-201 and Tc-99m pyrophosphate studies were 
performed on day 5 after infarction. 
All single-photon tomographic studies were performed with 
a large-field-of-view, rotating single-head gamma camera 
(Philips Diagnost A) using a low energy, high resolution 
collimator. For the Tl-201 scans, 120 MBq of thallous chloride 
was injected intravenously. For Tc-99m pyrophosphate scans, 
800 MBq of the tracer was injected intravenously 4 h before 
imaging. Acquisition windows were centered on the 69- to 
80-keV Hg X-ray photopeak of II-201 and the MO-keV 
photopeak of Tc-99m with a 20% window width. The studies 
were performed using a 180” camera rotation, from left 
posterior oblique to right anterior oblique projectrons in 32 
steps, with a I-min count time at each step. The total counts in 
reconstructed tomographic slices averaged 350,OlHl for Tl-201 
and 330,000 for Tc-99m pyrophosphate. For dual-energy ac- 
quisitions, n-201 counts were corrected for down-scattered 
Tc-99m counts with use of a convolution subtraction technique 
(W 
Reconstruction and analysis of the tomographic data were 
performed by technologists who were unaware of the clinical 
status of the patients and their QRS scores. Tbe radionuclide 
projection data were processed with a Metx filter to effect 
resolution recovery and reduce image noise before reconstruc- 
tion (24,25). A PDP-11 computer (Digital Equipment t&po- 
ration) reconstructed the filtered data using back projection 
with a ramp filter cutoff at the Nyquist frequency. The spatial 
resolution of the reconstructed images for Tl-201 was approx- 
imately 22 mm full-width half-maximum, and for Tc-99m 
approximately 16 mm full-width half-maximum. The ream- 
strutted images were reoriented along the long axis of the left 
ventricle and sectioned into contiguous short-axis slices of 
3 mm thickness. Regional count activity in each slice was 
referenced to the peak count activity of the left ventricle (26). 
A cinmlar region of interest was centered on the left ventric- 
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ular cavity, and circumferential profiles for each slice deter- 
mined from maximal count acti&j along 60 radii from the 
cavity center. The TM01 perfusion cicfects were defined as the 
radial sectors where myocardial count activity was ~70% of 
peak activity. Sectors with count activity <500/c of peak activity 
were regarded as infarcted myocardium (27). For the Tr 99m 
pyrophosphate scans, the. infarct region in each slice was 
defined as the radial sectors where myocardial count activity 
was >65% of peak activity (2829). 
The volumes of myocardium within the TM01 perfusion 
defect and the Tc-99m pyrophosphate infarct region were 
calculated according to Simpson’s rule. For each 3-mm thick 
myocardial slice, the diameter of the slice was measured from 
the tomographic image (1 pixel = 3.125 x 3.125 mm), and the 
slice volume calculated assuming an average wall thickness of 
9 mm. All myocardial slices were included in the analysis 
except for the most apical slices, where no cavity was visible 
and no accurate circumferential profile could be calculated. 
The number of se.ciors in each slice that were ~70% or <SO% 
of peak Tl-201 acrivity were summed to calculate the extent of 
the TM01 perfusion defect and necrotic myocardium. respec- 
tively, in that slice. These volumes were then summed for all 
slices to cak ulate the extent of the risk region and of necrotic 
myocardium as a proportion of total left ventricular volume. 
The Tc-99m pyrophosphate scan slices were registered in the 
same position as the corresponding ‘IL201 slice, and the same 
regions of interest were used for the ‘Il-201 and Tc-99m 
pyrophosphate data. Within each region of interest, all sectors 
with >65% peak Tc-99m activity were summed to determine 
the infarct volume per slice. The data from each slice were then 
summed to calculate infarct volume, which was then compared 
with the volume of the left ventricle calculated from the TM01 
scans. 
Data aaalysls. Demographic variables were compared be- 
tween patient groups by Student t test or chi-square testing as 
appropriate (30). Serial QRS scores within each patient group 
were compared by analysis of variance with Newman-Keuls 
comparison of group means. Relations between total QRS 
scores and radionuclide measurements of risk region and 
infarct size were compared by linear regression analysis. Re- 
sults are reported as mean value 5 SD for group data, and p < 
0.05 is reported as signilicant. 
Results 
Patient group. Thirtyeight consecutive patients presenting 
with a first infarction were studied, of whom 18 had anterior 
and 20 had inferior infarcts. The characteristics of these 
patient groups are summarixed in Table 1. The iverage time 
fromonsetofchestpaintothefirstECGwas-2hineach 
group. The time to thromholytii therapy and the hemodynamic 
findiogswerpalsosimilarinthetwogroupsAmong12patients 
with anterior iduct who underwent coronary angiography, 
the i&r&related artery was Thrombolysis in Myoca&l 
hfarction (TM) grade 3 in 9. Among 15 patients with 
Table 1. Characteristics of Patient Groups According to Infarct Site 
Anterior MI Infcriw MI 
(n = IA) (II = 20) 
Age W 
Male/female 
Time IO admission ECG 
(min) 
Tii IO lhrmnholytic 
therapy (min) 
Heart rate (heawmin) 
BLJOII pr=== (mm Hg) 
54-c I4 .54 2 8 
17/l I7/3 
136 2 S6 lo8?81 
I71 % 78 I52 2 a7 
77 5 16 71 + I? 
SysIdic 144k21 135 % 32 
Diastdic 872 I2 u3t I9 
QRS rare 
Day 0 (potential maximal) IO.3 2 3.1 lO~k35 
hYl 6.1 t 3.5’ 4.1 + 2.9’ 
Day3 6.1 z 3.8’ 3.8 c 2.8’ 
bY7 5.6 ? 3.4’ 3.7 r 2.6’ 
Day30 5.5 + 3.4’ 2.9 2 2.2*t 
LV cjxtion fraction (Q) 
2; 
51 -t9 56 t 9 
49? I3 56-c8 
*p < 0.01 versus day 0 (potential maximal QRS scow). tt, < 0.05 ~crsu~ 
anterior infarction. Data presented arc mean value ? SD or number of patients. 
ECC = eiectnxardiographiq LV = leh ventricular, Ml = myocardial infarction. 
inferior infarcts who had coronary angiography. the infarct- 
related artery was TIM1 grade 3 in 12 patients. 
QRS sawe and Maret site. Although the maximal poten- 
tial QRS scores at admission (day 0) were similar, patients with 
anterior infarcts had larger QRS scores at 7 days and 1 month 
than did patients with inferior infarcts (Table 1). The QRS 
scores at 7 days were markedly less than the maximal potential 
score on admissiin (p < 0.01 in both groups). The QRS scores 
decreased slightly between day 1 and day 30, but the differ- 
ences were not sign&ant for either anterior or inferior 
infarcts. There was no signiit change between day 7 and 
day 30. 
Examples of paired Tl-201 and Tc-99m pyrophosphate 
images are shown in Figure 1 for two patients with anterior 
infarcts. The images have been volume rendered (Voxel View, 
Vital Images Inc.) and color coded to compare the normal and 
infarcted myocardial regions. Regions of normal n-201 uptake 
are shown in red, and regions of Tc-99m mte uptake 
areshownioMue.InPanelsAandB,scansareshownfora 
patient with a small infarct. ‘Ihis patient had a potential 
maximal QRS score of 8 (qgesting an ischemic risk region of 
-24% of the left ventricle) at admission and a QRS score of 0 
on day 7. The corresponding n-201 perfusion defect was 21% 
of the left ventricle, and the subsequent infarct sixe on Tc-99m 
pyrophosphate was 4% of the ventricle, which are similar to 
thepred&iomfromtheQRSsanes.Acontrastingexampleis 
showainpanekCandD.ThispatienthadapdentialQRS 
scoreoflOonadt&&n(sugges@anischemicriskregionof 
-30% of the left ventricle) and a subsequent infa~ QRS 
score of 5 on day 7, indicating an infarct size. of 15% of the 
ventricle. The corresponding Tl-201 scan showed a perhrsion 
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F@e1.GnnpkanofpiredIWO1andTc-9!hpyqho@ate 
sfaminaptientwithaverysmallanteriorinfarct(AandB)and$a 
patient with a m&rat&y large anterior infarct (C and D). The xa~ 
ofIbeleftventridehiwebeenwtumerenderedfromtheotiginal 
tomognphicdstaandarcviewedfromthefront,w,thrttheantermr 
kftvmtrieulrrwailidosesltothcviearer.InpurekAandC,the 
nomdy perfused myucardium (regional Tl-201 uptake >70% of peak 
~vi~)kshowninre4andlhe~icrbi:rebionk~nasa 
perfusionMect.InpanekBandlJtbeinfarctedmywardium 
(regional Tc-9!h Wrophosphate uptake >65% of peak zdvity) is 
showninbkcandksuperimposedonthecomspondingll-201 
perfwion scan. Regions of nouinfarcted myocardium within the Tl-201 
perfusion defect remain uncolored. 
defect of 28% of the left ventricle. and the infarct sire on 
Tc-99m wophosphate scan was 19% of the ventricle. 
The QRS scores and radionuclide measurements of the 
ischemic risk region and infarct size are summarized in Table 
2 for the 28 patients who had radionuclide tomography studies 
The ll-291 scaos were of sufficient quality for quantification in 
all patients. Two patients with large anterior infarcts and 
persistent occlusion of the infaa artery had poor quality 
Tc-9!h pyn@o@ate scans that could not be qu~riikd. The 
individual QRS score and TWO1 estimates of the extent of the 
ixhemic region and infarct size are compared in Figure 2. The 
patients who had ‘IT-201 scans on ~dmissiin are sho;.n as 
closed symbols, and those who had IWO1 scans on day 5 are 
show as open symbols. ‘there were no ditTerences in the 
relations between QRS scores and radionuclide measurements 
of the ischemic risk region or ikuct size between patients with 
‘II-MI scans on day 0 or dy 5, and accordingly, these patients 
are grouped for analysii In the tq panel, the univziate 
relation between summed potential maximal QRS score on 
admkion (OR&,) ts compared with the extent cf the TWOI 
risk region. l%e poteotial maximal QRS scores ranged from 4 
to I5 (-12% to 45% of the ventti:de. assllllljng 3% per QRS 
point) (9-11). The overall cozrelatioo was r = 0.79, nth a 
staodard error of the rcgfesh of 5.8~. In the center panel. 
T&k 2. QRS Score and Radionuclide Measurements of Risk 
Region and Infarct site 
owsawe 
Llay 0 (pntential maximum) 
gJ 
QRsday7MayO(Q) 
I’M31 SPECT 
Tl-XII rkk regh (S LJ) 
11-201 inhrcl (a LV) 
TMO: illfati (a) 
rc~~-e 
Anlelitn tllktior 
MI MI 
P =: 13 n = IS 
Y.8 z ‘9 10.4 +_ 3.3 
5.1 z 33 3.6 2 23 
4.9 z 23t 2.9 * 1.m 
$7 + 3 _- - 34 2 2’ 
n= 13 n = IS 
.M.4? II.? 323 2 7.3 
Za9 -! 11.8 17.3 z 7.6 
HJ.8 r 21.4 53.1 z 17.6 
n-11 0 = IS 
T&h idand (% Lb’) I45 t 9.4 I65 2 8.9 
Tc-9% inbdrisk (d4) 422 2 25.8 51.0 2 310 
l p<O.Q5~lntcmr~~tp<o.0lvmusdr~O(pnccntialrm6nl 
the QRS score on day 7 (QRS,) is compared with the TWO1 
measurement of necrotic myocardium. The day 7 QRS scores 
ranged from 0 to 14, and the rcgession relation bad a 
correlation coellkieot of 0X3. with an error of 5.4%. Tire QRS 
scoreonday7isakocomparedwithinfarctsizemcxuWedby 
Tc-99m WroPhosphate in the lower panel, with a correlation 
coeflicientof0.79andastan&rdeenoroftheregreskof 
6.4%. There was oo signifkaut diSerence in slope between the 
ll-201 and the Tc-99m Wrophosphate infarct size regekuu 
The previously validated univariate regre&n re$tirms 
between QRS score and anatomic infarct size (13) were then 
used to estimate the anatomic extent of the kchemk risk 
regioo aod infarct size for the current p&at gnxp. Tk 
QRS-estimated sire of the ischemic risk region is compmed 
with the TN01 perfusion defect in Fiqure 3 (rap panel). The 
regression relation had a cxrelation coeRkieot of 0.76, but the 
slope of the rclatioo (0.73) wa <I. In 16 of 26 patients, the 
difference between the QRS and TWOI oleawremcots was 
<7% of left ventricular volume: in 24 of B, it was <lO% of 
ventricular voiume. Tbe QRS-estimated infarct size is com- 
pred with the extent of necrotic myncardium on TWO1 scan in 
the center panzl. .The correlation between the QRS 
and radionuclide nrc~urements was 0.82. with a sbpe of 
f~.87, which did not differ significantly from the line of 
identity. Overall, in X of B paben& the QRS and TM01 
measurements di,‘exd ‘y ~7% of ventricular volume. and in 
16of~t~d~err:Icewas<l~.TheQRSestimatedinfara 
size is ampared with infarct size measured by Tc-99~ 
Wrophaghate in the lower panel. This relation (r = 0.76) had 
a similar stope (0.94) to the II-XII relation but a sli@Jy 
greater error (7.9% vs. 5.6%). In 18 d 26 patients, the QRS 
and Tc-9rkn pymp&pktc rneasumne~ difercd by <7%. 
andin25of~thejiferenoewrc<l~dveo~vohne. 
z- 
t a 
5 1 
Y=l..+as4# 
r=WEha-tlb 
P(-f 
A / 
tE c 5 n a 55 
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mighi be an unreliable measure of infarct size after thrombol- 
ysk 
Recently. Christian and co-workers (18) found no aurela- 
tion between the 29-point QRS score and infarct size measured 
by Tc-%I isonitrile single-photon emission computed tomog- 
raphy. This observation is contrary to previous anatomic 
findings (11-13). The present study finds that infarct size 
measured by the 32-point score is correlated with Tc49tn- 
pyrophosphate measurements of infarct size. Several factors 
may account for the difference between this study and the 
paiou5 one. The 32-point score is more accurate than the 
29point system for measurement of infarct size in inferior and 
posterolaterai infarcts (13). In p&cular, we inch&d scores 
for leads V, and V, for posterior extension and leads Vs and 
V, for lateral extenstoir of inferior infarcts. Qur earlier studies 
have shown that past&x extension of inferior infarcts in the 
presence of a domin.:r.t right coronary artery. is a significant 
contributor to infarr? sixe (19,201. Faihtre to include these 
leads in the QRS score may underestimate infarct size. An- 
other factor is that we have ana@& the n-201 and Tc-99m 
pyrophosphate studies according to Stmpson’s rule rather than 
using a simple geometric model of the left ventricle. We 
believe that this approac;~ provides a more accurate measure of 
infarct size without assumption5 regarding ventrieuhu geane- 
try, especially when large i:ifarcts can rc‘sult in regkmal dilata- 
tion of the ventricle. This approach is also -loser to the usual 
anatomic pathology practice of slicing the myocardium and 
planimetry of infarct regions as a proportion of the cross- 
sectional area of each mvtrardial slice. Finally, there is a 
potential complication to measurements with Tc--ted 
perfusion agents in that these tracers may overestimate infarct 
size and underestitna:e residual myocardial viability (32-34). 
This study used Tc-99m pyropbosphate to measure infarct 
size. This tracer accumulates within necrotic myocardium and 
can be used to measure infarct size after 5 to 7 days, but infarct 
size may be overestimated during the first 3 days after infarr- 
bon (2829). Roth iufarct site and extent, measured by Tc-99m 
pyrophosphate. have been shown to correlate with anatomic 
and Mum-I 11 antimyosin measurements of infarct size (35). 
Infarct size was also measured by the extent of a severe 
perfusion defect on Tl-201 scintigramf. where the necrotic 
myocardium was defined as myoeardial sectors with Tl-201 
count activity 40% of the peak activity for the ventricle. This 
criterion is similar to that established by other invest@tors for 
definition of nonviable myocardium and has been shown to 
correlate with F-18 2deoxyghra~ studies of tiryocardial via- 
bility (27). For both Tc-99m Wmphosphate and Tl-201 mea- 
surermznts of the extent of necn& theQRSscureat7days 
correlated with the radionuchde measurements 
QRSseerc8udisebmkcriskreg& Thepresentfindings 
atsosuggestthattheQKSscwe~ht~toc\linrrtethe 
extent of the iAemic risk region during the acute phase of 
infarction. Crdculation of the maximal potential QRS score is 
kedontheprelni5eth6tcompkteillfamiondtherist 
regionwookf~nthe maxiaulQRSsaueforeachlead 
showing ST elevatlln. This premise is w b body 
Y = 62.3 - 0.92X - 0.12X2 
r = -0.741 
p t 0.01 
0 
\ 
3 0 .- --* \ ___.T-__*T_ 
0 5 10 I5 20 
ORS SCORE ON DAY 7 
Filpvc 4. The inverse and noniinear relafionship between the QRS 
sam cm day 7 after infarction and the left ventrAat (LV) ejection 
fraction at I month aher infarction. 
QRS score was <5 but a marked reduction in ejectton fraction 
when the QRS score was 28. 
Discussion 
Thromlxrlytic therapy aims to limit infarct size by early 
reperfusion of the infarct artery and interruption of the 
wavefront of necrosis advancing from subendocardium to 
subepicardium in the ischemic myoeardium. Definition of the 
extent of the ischemic myocardium may be an important factor 
in determining the best immediate treatment, such as angio- 
piasty or thrombolysic. EvAration of the etficacy of :reatment 
efforts requires comparison of final infarct size with the 
original extent of the ischemic myocardium. Radionuclide 
studies using Tc-99m-labeled perfusion agents that are well 
retained within the myocardium have enabled comparisons 
between the risk region and later infarct size (6). Unfortu- 
nately, the logistics of radionuclide studies preclude their use. 
in many patients presenting with acute infarction, when imme- 
diate information is required about the ischemic myocardium 
for eariy treatment decisions. Several ECG methods of mea- 
suring infarct size have been developed (7-10). but the utility 
of these methods for measuring the extent of the ischemic 
region or subsequent infarct size in patients receiving throm- 
bolytic thetapy is unproved 
QRS scwe ud iniarct size. l%e Setvester QRS scoring 
system was developed as a measure of infarct size before the 
current use of thrombolytic therapy. The scoring system has 
been validated against anatomic measurements of infarct size 
(11-13). Clinical studies have shown that the QRS score is 
inversely correlated with left ventricular sytolic function after 
infarction (II). With the use of thrombolytic therapy, the 
validity of the QRS score as a measure of infarct siu: has been 
questd Studies with tluorine (FF18 2deoxygiucosc and 
positron es* tomography show that viable myocardium 
may persist within the infarct region despite Q wave5 on the 
5urf;loe ECG (31). and residual riatdily k mom likely after 
thromhdysa.AtthoughtheQRSsrureisscakdamudingto 
the size of Q waves and R and S wave amplitudes the score 
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l3perislentalevidenaSbUWStllatTl-201uptaLcill* 
postiscbemicmyocardiumremainslessthanthatdoorlnal 
myocadh even lace after reperfusion of the infarct artery 
(3&40).Aplimimydiaicalrcportiodicatcsthatthebca- 
tioaandextentdthell-2lMperlkoodefectat5daysis 
kiiartothatoftbekcbemicriskregioamemredbyTc-!Wm 
isoohik at the time d infarction (41). Two other clinkal 
studiesakopmideinfamakanthisquestimArepottby 
DeCosteretd(42)~thaltheseveritysooreofan-201 
pelflsimdefeuwasunchangedbetmenddmi.*aadday4 
inpatkltswithout~dtbeiofarctartery.1opatieotx 
withllzpe~~pemaiondefectswerestillevidcat 
at day 4, bca tbe semity score decreastdIoasimilarstuJy, 
HeUeretai.(43)buodthattbetha%mdefectsc9feat lOdays 
wassimibrtothat~arithio1hdtbrombdytictherapy. 
CoUeuively, these shdies suggest that the Tl-201 defect at 5 
daysislikelytobea msombiemeasurrcfthetientdthe 
?scbemic risk regioo. IO the plx.seM study, there wn: 110 
ohcred diferemces io the datioas between OR& and 
extent of the IWO1 pexfusb dcfcct for II-201 scans per- 
fomedaftimed~orat5days.Anyq*ematic 
ctmpeuwtolychaogaillamtlactik~dlKJaiofarcted 
regiomontheejeGhfla&o. 
t.Xmkd~This~smlrprtrnxedthe32- 
pointQRssamfore3timationdextentdt&kchemicrisk 
r~aodsubsegoeotinfarctsite.Thipstudymedmarual 
tqscorioghutmaknlm-~hep 
gmmed to cakdate the QRS same automarially (14). lk 
omximalpotentialQR!Sscorepmidesaoeaioutedtbe 
extentdtheis&emicrisk~andsbwldprovewefblin 
thCt%lUgCnCyra#nfa~~dIUiOg~*- 
tiomCaaparboadtbeQRSsconat7dn)switbtbehitisl 
umimaiptentklsmreallowsevahiationdmpardLlsab 
me- 
pected. The Qk score was or&ally amehted with ejection iii%t53:87~8. - - - . 
tractionbetbrccurrentuseofthrombolyktberapywasestab il. i&kcrREWagmCS+bW’i,ctaLEvakimdrORS~~ 
lkhed (17). Itis study amtinm the relation betwxn tbe QRS 
fa atiuthg wKul&d dalu Sk. I1 cardria milb qafwm 
alka&&bf raVmr ibrar. .km J G&i 3962~1601-14. 
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